Research ArticleDiabetes

Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes

See allHide authors and affiliations

Science Translational Medicine  14 Jun 2017:
Vol. 9, Issue 394, eaah4477
DOI: 10.1126/scitranslmed.aah4477

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

  • RE: Sulforaphane Increases Testosterone which Decreases Type 2 Diabetes
    (15 June 2017)

    I suggest the basis of these findings is increased testosterone.

    Low testosterone may be the basis of the symptoms called type 2 diabetes. It is known that sulforaphane increases testosterone. (Testosterone is not mentioned in this article, at least not in the material available at Science Translational Medicine.)

    Competing Interests: None declared.

View Full Text

Article Tools

My saved folders

Stay Connected to Science Translational Medicine

Related Content

Similar Articles in:

Citing Articles in:

Navigate This Article